Associated partners

Johann Wolfgang Goethe-Universität Frankfurt

The Goethe University Frankfurt/Main is active in the DZIF research areas Hepatitis and Healthcare-Associated and Antibiotic-Resistant Bacterial Infections.

In the Hepatitis research area, a collaborative project is taking place, among others, to optimise the treatment of hepatitis C patients with novel agents—so-called Directly Acting Antivirals (DAA)—and to develop a prophylactic vaccine. The Goethe University is also involved in a DZIF study on the treatment of hepatitis E.

Goethe University Frankfurt/Main